Intermittent continuous infusion of 5-fluorouracil and low dose oral leucovorin in patients with gastrointestinal cancer: Relationship between plasma concentrations and clinical parameters
- 30 September 1995
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (9) , 1465-1470
- https://doi.org/10.1016/0959-8049(95)00217-7
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Systemic Infusion Versus Bolus Chemotherapy with 5-Fluorouracil in Measurable Metastatic Colorectal CancerAmerican Journal of Clinical Oncology, 1992
- Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project.Journal of Clinical Oncology, 1992
- Clinical relevance of biochemical modulation of 5-fluorouracilAnnals of Oncology, 1991
- Systemic Therapy in Metastatic Colorectal CancerArchives of internal medicine (1960), 1990
- Randomized study of continuous infusion fluorouracil versus fluorouracil plus cisplatin in patients with metastatic colorectal cancer.Journal of Clinical Oncology, 1990
- A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study.Journal of Clinical Oncology, 1989
- Overview of clinical trials using 5-fluorouracil and leucovorin for the treatment of colorectal cancerCancer, 1989
- Efficacy of high-dose oral leucovorin and 5-fluorouracil in advanced colorectal carcinoma. Plasma and tissue pharmacokineticsCancer, 1989
- Clinical experience with leucovorin and 5-fluorouracilCancer, 1989
- Comparison of continuously infused 5-fluorouracil with bolus injection in treatment of patients with colorectal adenocarcinomaCancer, 1975